Lecozotan (developmental code name SRA-333) is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients. As of, the first Phase III clinical trial has been completed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.